Perceived barriers to assessing understanding and appreciation of informed consent in clinical trials: A mixed-method study

Abstract Introduction: Participants and research professionals often overestimate how well participants understand and appreciate consent information for clinical trials, and experts often vary in their determinations of participant’s capacity to consent to research. Past research has developed an...

Full description

Bibliographic Details
Main Authors: Erin D. Solomon, Jessica Mozersky, Kari Baldwin, Matthew P. Wroblewski, Meredith V. Parsons, Melody Goodman, James M. DuBois
Format: Article
Language:English
Published: Cambridge University Press 2021-01-01
Series:Journal of Clinical and Translational Science
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S2059866121008074/type/journal_article
_version_ 1811156612099866624
author Erin D. Solomon
Jessica Mozersky
Kari Baldwin
Matthew P. Wroblewski
Meredith V. Parsons
Melody Goodman
James M. DuBois
author_facet Erin D. Solomon
Jessica Mozersky
Kari Baldwin
Matthew P. Wroblewski
Meredith V. Parsons
Melody Goodman
James M. DuBois
author_sort Erin D. Solomon
collection DOAJ
description Abstract Introduction: Participants and research professionals often overestimate how well participants understand and appreciate consent information for clinical trials, and experts often vary in their determinations of participant’s capacity to consent to research. Past research has developed and validated instruments designed to assess participant understanding and appreciation, but the frequency with which they are utilized is unknown. Methods: We administered a survey to clinical researchers working with older adults or those at risk of cognitive impairment (N = 1284), supplemented by qualitative interviews (N = 60). Results: We found that using a validated assessment of consent is relatively uncommon, being used by only 44% of researchers who had an opportunity. Factors that predicted adoption of validated assessments included not seeing the study sponsor as a barrier, positive attitudes toward assessments, and being confident that they had the resources needed to implement an assessment. The perceived barriers to adopting validated assessments of consent included lack of awareness, lack of knowledge, being unsure of how to administer such an assessment, and the burden associated with implementing this practice. Conclusions: Increasing the use of validated assessments of consent will require educating researchers on the practice and emphasizing very practical assessments, and may require Institutional Review Boards (IRBs) or study sponsors to champion the use of assessments.
first_indexed 2024-04-10T04:54:16Z
format Article
id doaj.art-e9e3627287f44a808743d9f922bed314
institution Directory Open Access Journal
issn 2059-8661
language English
last_indexed 2024-04-10T04:54:16Z
publishDate 2021-01-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj.art-e9e3627287f44a808743d9f922bed3142023-03-09T12:31:02ZengCambridge University PressJournal of Clinical and Translational Science2059-86612021-01-01510.1017/cts.2021.807Perceived barriers to assessing understanding and appreciation of informed consent in clinical trials: A mixed-method studyErin D. Solomon0https://orcid.org/0000-0002-3295-0698Jessica Mozersky1https://orcid.org/0000-0002-4942-4571Kari Baldwin2Matthew P. Wroblewski3https://orcid.org/0000-0002-5256-2414Meredith V. Parsons4https://orcid.org/0000-0002-8869-3766Melody Goodman5https://orcid.org/0000-0001-8932-624XJames M. DuBois6https://orcid.org/0000-0002-3712-7051Bioethics Research Center, Washington University School of Medicine, St. Louis, MO, USABioethics Research Center, Washington University School of Medicine, St. Louis, MO, USABioethics Research Center, Washington University School of Medicine, St. Louis, MO, USABioethics Research Center, Washington University School of Medicine, St. Louis, MO, USABioethics Research Center, Washington University School of Medicine, St. Louis, MO, USASchool of Global Public Health, New York University, New York, NY, USABioethics Research Center, Washington University School of Medicine, St. Louis, MO, USA Abstract Introduction: Participants and research professionals often overestimate how well participants understand and appreciate consent information for clinical trials, and experts often vary in their determinations of participant’s capacity to consent to research. Past research has developed and validated instruments designed to assess participant understanding and appreciation, but the frequency with which they are utilized is unknown. Methods: We administered a survey to clinical researchers working with older adults or those at risk of cognitive impairment (N = 1284), supplemented by qualitative interviews (N = 60). Results: We found that using a validated assessment of consent is relatively uncommon, being used by only 44% of researchers who had an opportunity. Factors that predicted adoption of validated assessments included not seeing the study sponsor as a barrier, positive attitudes toward assessments, and being confident that they had the resources needed to implement an assessment. The perceived barriers to adopting validated assessments of consent included lack of awareness, lack of knowledge, being unsure of how to administer such an assessment, and the burden associated with implementing this practice. Conclusions: Increasing the use of validated assessments of consent will require educating researchers on the practice and emphasizing very practical assessments, and may require Institutional Review Boards (IRBs) or study sponsors to champion the use of assessments. https://www.cambridge.org/core/product/identifier/S2059866121008074/type/journal_articleInformed consentassessmentvalidated assessmentsresearch ethicsimplementation science
spellingShingle Erin D. Solomon
Jessica Mozersky
Kari Baldwin
Matthew P. Wroblewski
Meredith V. Parsons
Melody Goodman
James M. DuBois
Perceived barriers to assessing understanding and appreciation of informed consent in clinical trials: A mixed-method study
Journal of Clinical and Translational Science
Informed consent
assessment
validated assessments
research ethics
implementation science
title Perceived barriers to assessing understanding and appreciation of informed consent in clinical trials: A mixed-method study
title_full Perceived barriers to assessing understanding and appreciation of informed consent in clinical trials: A mixed-method study
title_fullStr Perceived barriers to assessing understanding and appreciation of informed consent in clinical trials: A mixed-method study
title_full_unstemmed Perceived barriers to assessing understanding and appreciation of informed consent in clinical trials: A mixed-method study
title_short Perceived barriers to assessing understanding and appreciation of informed consent in clinical trials: A mixed-method study
title_sort perceived barriers to assessing understanding and appreciation of informed consent in clinical trials a mixed method study
topic Informed consent
assessment
validated assessments
research ethics
implementation science
url https://www.cambridge.org/core/product/identifier/S2059866121008074/type/journal_article
work_keys_str_mv AT erindsolomon perceivedbarrierstoassessingunderstandingandappreciationofinformedconsentinclinicaltrialsamixedmethodstudy
AT jessicamozersky perceivedbarrierstoassessingunderstandingandappreciationofinformedconsentinclinicaltrialsamixedmethodstudy
AT karibaldwin perceivedbarrierstoassessingunderstandingandappreciationofinformedconsentinclinicaltrialsamixedmethodstudy
AT matthewpwroblewski perceivedbarrierstoassessingunderstandingandappreciationofinformedconsentinclinicaltrialsamixedmethodstudy
AT meredithvparsons perceivedbarrierstoassessingunderstandingandappreciationofinformedconsentinclinicaltrialsamixedmethodstudy
AT melodygoodman perceivedbarrierstoassessingunderstandingandappreciationofinformedconsentinclinicaltrialsamixedmethodstudy
AT jamesmdubois perceivedbarrierstoassessingunderstandingandappreciationofinformedconsentinclinicaltrialsamixedmethodstudy